Total Payments
$14,686
2023 Payments
$31.21
Companies
6
Transactions
23
Medicare Patients
1,190
Medicare Billing
$91,410
Payment Breakdown by Category
Other$10,075 (68.6%)
Consulting$2,450 (16.7%)
Travel$1,614 (11.0%)
Food & Beverage$464.63 (3.2%)
Education$82.55 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,075 | 7 | 68.6% |
| Consulting Fee | $2,450 | 1 | 16.7% |
| Travel and Lodging | $1,614 | 4 | 11.0% |
| Food and Beverage | $464.63 | 8 | 3.2% |
| Education | $82.55 | 3 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $11,521 | 11 | $0 (2020) |
| PTC Therapeutics, Inc. | $2,936 | 7 | $0 (2018) |
| Lilly USA, LLC | $146.41 | 2 | $0 (2023) |
| Biogen, Inc. | $58.65 | 1 | $0 (2020) |
| Mitsubishi Tanabe Pharma America, Inc. | $12.74 | 1 | $0 (2017) |
| Akcea Therapeutics, Inc. | $11.16 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $31.21 | 1 | Lilly USA, LLC ($31.21) |
| 2022 | $115.20 | 1 | Lilly USA, LLC ($115.20) |
| 2020 | $9,522 | 10 | Alexion Pharmaceuticals, Inc. ($9,452) |
| 2019 | $2,069 | 3 | Alexion Pharmaceuticals, Inc. ($2,069) |
| 2018 | $2,936 | 7 | PTC Therapeutics, Inc. ($2,936) |
| 2017 | $12.74 | 1 | Mitsubishi Tanabe Pharma America, Inc. ($12.74) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/22/2023 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $31.21 | General |
| Category: Neuroscience | ||||||
| 09/28/2022 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $115.20 | General |
| Category: Neuroscience | ||||||
| 12/15/2020 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $630.00 | General |
| Category: Immunology | ||||||
| 11/10/2020 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: Immunology | ||||||
| 11/03/2020 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Travel and Lodging | In-kind items and services | $621.00 | General |
| Category: Immunology | ||||||
| 11/03/2020 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Food and Beverage | In-kind items and services | $75.91 | General |
| Category: Immunology | ||||||
| 09/15/2020 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $630.00 | General |
| Category: Immunology | ||||||
| 07/28/2020 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,260.00 | General |
| Category: Immunology | ||||||
| 07/14/2020 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $735.00 | General |
| Category: Immunology | ||||||
| 06/01/2020 | Akcea Therapeutics, Inc. | TEGSEDI (Drug) | Education | In-kind items and services | $11.16 | General |
| Category: NEUROLOGY | ||||||
| 05/07/2020 | Biogen, Inc. | SPINRAZA (Biological) | Education | In-kind items and services | $58.65 | General |
| Category: NEUROLOGY | ||||||
| 01/29/2020 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,350.00 | General |
| Category: Immunology | ||||||
| 12/03/2019 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Travel and Lodging | In-kind items and services | $675.00 | General |
| Category: Immunology | ||||||
| 12/03/2019 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $74.02 | General |
| Category: Immunology | ||||||
| 07/15/2019 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,320.00 | General |
| Category: Immunology | ||||||
| 08/17/2018 | PTC Therapeutics, Inc. | Emflaza (Drug) | Consulting Fee | Cash or cash equivalent | $2,450.00 | General |
| Category: Muscular Dystrophy | ||||||
| 08/17/2018 | PTC Therapeutics, Inc. | Emflaza (Drug) | Travel and Lodging | In-kind items and services | $207.10 | General |
| Category: Muscular Dystrophy | ||||||
| 08/17/2018 | PTC Therapeutics, Inc. | Emflaza (Drug) | Travel and Lodging | In-kind items and services | $110.88 | General |
| Category: Muscular Dystrophy | ||||||
| 08/17/2018 | PTC Therapeutics, Inc. | Emflaza (Drug) | Food and Beverage | In-kind items and services | $36.75 | General |
| Category: Muscular Dystrophy | ||||||
| 08/17/2018 | PTC Therapeutics, Inc. | Emflaza (Drug) | Food and Beverage | In-kind items and services | $29.39 | General |
| Category: Muscular Dystrophy | ||||||
| 08/17/2018 | PTC Therapeutics, Inc. | Emflaza (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Muscular Dystrophy | ||||||
| 08/16/2018 | PTC Therapeutics, Inc. | Emflaza (Drug) | Food and Beverage | In-kind items and services | $84.43 | General |
| Category: Muscular Dystrophy | ||||||
| 11/30/2017 | Mitsubishi Tanabe Pharma America, Inc. | Radicava (Drug) | Education | In-kind items and services | $12.74 | General |
| Category: Amyotrophic Lateral Sclerosis | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 229 | 259 | $117,471 | $15,682 |
| 2022 | 8 | 270 | 298 | $130,038 | $19,969 |
| 2021 | 9 | 340 | 404 | $149,742 | $31,969 |
| 2020 | 10 | 351 | 388 | $123,813 | $23,791 |
Total Patients
1,190
Total Services
1,349
Medicare Billing
$91,410
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 40 | 49 | $20,924 | $5,241 | 25.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 48 | 51 | $15,522 | $3,100 | 20.0% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2023 | 16 | 18 | $21,756 | $1,788 | 8.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 18 | 18 | $8,455 | $1,700 | 20.1% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2023 | 20 | 20 | $19,149 | $1,303 | 6.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 44 | 45 | $11,637 | $1,299 | 11.2% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2023 | 20 | 20 | $15,700 | $852.07 | 5.4% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Facility | 2023 | 23 | 38 | $4,328 | $398.76 | 9.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 48 | 59 | $23,468 | $6,070 | 25.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 46 | 49 | $14,161 | $3,458 | 24.4% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2022 | 36 | 36 | $33,002 | $2,519 | 7.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 15 | 20 | $7,840 | $2,496 | 31.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 59 | 60 | $14,963 | $1,938 | 13.0% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2022 | 15 | 15 | $17,700 | $1,543 | 8.7% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2022 | 17 | 17 | $12,931 | $870.17 | 6.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 16 | 16 | $3,100 | $728.70 | 23.5% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Facility | 2022 | 18 | 26 | $2,873 | $346.76 | 12.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 95 | 136 | $49,793 | $13,769 | 27.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 42 | 45 | $12,164 | $3,474 | 28.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 21 | 26 | $9,529 | $3,247 | 34.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 23 | 23 | $12,123 | $3,091 | 25.5% |
| 95910 | Nerve transmission studies, 7-8 studies | Facility | 2021 | 22 | 22 | $19,698 | $1,865 | 9.5% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Facility | 2021 | 47 | 50 | $11,724 | $1,741 | 14.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 16 | 16 | $6,540 | $1,640 | 25.1% |
| 95909 | Nerve transmission studies, 5-6 studies | Facility | 2021 | 28 | 28 | $20,616 | $1,577 | 7.6% |
About Dr. Scott Friedenberg, M.D
Dr. Scott Friedenberg, M.D is a Clinical Neurophysiology healthcare provider based in Danville, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811964893.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Friedenberg, M.D has received a total of $14,686 in payments from pharmaceutical and medical device companies, with $31.21 received in 2023. These payments were reported across 23 transactions from 6 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($10,075).
As a Medicare-enrolled provider, Friedenberg has provided services to 1,190 Medicare beneficiaries, totaling 1,349 services with total Medicare billing of $91,410. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Neurophysiology
- Other Specialties Neurology
- Location Danville, PA
- Active Since 03/08/2006
- Last Updated 08/20/2020
- Taxonomy Code 2084N0600X
- Entity Type Individual
- NPI Number 1811964893
Products in Payments
- Soliris (Drug) $9,452
- Emflaza (Drug) $2,936
- SOLIRIS (Drug) $2,069
- EMGALITY (Drug) $146.41
- SPINRAZA (Biological) $58.65
- Radicava (Drug) $12.74
- TEGSEDI (Drug) $11.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.